All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know ALL.
The all Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the all Hub cannot guarantee the accuracy of translated content. The all and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The ALL Hub is an independent medical education platform, sponsored by Amgen, Autolus, Jazz Pharmaceuticals, and Pfizer and supported through an educational grant from the Hippocrate Conference Institute, an association of the Servier Group. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View ALL content recommended for you
What are the socioeconomic disparities in the access to pediatric clinical trials?
Featured:
During the 65th American Society of Hematology (ASH) Annual Meeting and Exposition, the ALL Hub spoke with Lena Winestone, University of California, San Francisco, US. We asked, What are the socioeconomic disparities in the access to pediatric clinical trials?
What are the socioeconomic disparities in access to pediatric clinical trials?
Winestone highlights the limited data surrounding the socioeconomic status of families of pediatric patients, resulting in the use of proxy measures, such as insurance status, race/ethnicity, and area-based measures such as neighborhood environment. There are also challenges in understanding the association between socioeconomic factors and clinical trial enrollment.
For the remainder of the discussion, Winestone reviews the existing data on race/ethnicity and socioeconomic disparities in access to clinical trials, including historical area-based data, patient-to-patient level data, and county-level data. She concludes by highlighting a report from the COG trials, which found no association between area-based socioeconomic measures and participation in clinical trials; interestingly, an association was observed with distance to care.
